Header
Header
Article

Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease



Ahmadi, Khazar;

Pereira, Joana B;

Berron, David;

Vogel, Jacob;

Ingala, Silvia;

Strandberg, Olof T;

Janelidze, Shorena;

Hansson, Oskar; + view all

Ahmadi, Khazar;

Pereira, Joana B;

Berron, David;

Vogel, Jacob;

Ingala, Silvia;

Strandberg, Olof T;

Janelidze, Shorena;

Barkhof, Frederik;

Pfeuffer, Josef;

Knutsson, Linda;

van Westen, Danielle;

Palmqvist, Sebastian;

Mutsaerts, Henk Jmm;

Hansson, Oskar;

– view fewer

(2022)

Gray matter hypoperfusion is a late pathological event in the course of Alzheimer’s disease.

Journal of Cerebral Blood Flow and Metabolism


10.1177/0271678X221141139.

Abstract

Several studies have shown decreased cerebral blood flow (CBF) in Alzheimer’s disease (AD). However, the role of hypoperfusion in the disease pathogenesis remains unclear. Combining arterial spin labeling MRI, PET, and CSF biomarkers, we investigated the associations between gray matter (GM)-CBF and the key mechanisms in AD including amyloid-β (Aβ) and tau pathology, synaptic and axonal degeneration. Further, we applied a disease progression modeling to characterize the temporal sequence of different AD biomarkers. Lower perfusion was observed in temporo-occipito-parietal cortex in the Aβ-positive cognitively impaired compared to both Aβ-negative and Aβ-positive cognitively unimpaired individuals. In participants along the AD spectrum, GM-CBF was associated with tau, synaptic and axonal dysfunction, but not Aβ in similar cortical regions. Axonal degeneration was further associated with hypoperfusion in cognitively unimpaired individuals. Disease progression modeling revealed that GM-CBF disruption Followed the abnormality of biomarkers of Aβ, tau and brain atrophy. These findings indicate that tau tangles and neurodegeneration are more closely connected with GM-CBF changes than Aβ pathology. Although subjected to the sensitivity of the employed neuroimaging techniques and the modeling approach, these findings suggest that hypoperfusion might not be an early event associated with the build-up of Aβ in preclinical phase of AD.

Download activity – last month
Download activity – last 12 months
Downloads by country – last 12 months

Archive Staff Only

View Item View Item



Source link

Back to top button